Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer - Concepedia

Concepedia

Publication | Open Access

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

DOI Full Paper Access

1.9K

Citations

7

References

2004

Year

Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G. Duda, Lance L. Munn, Ricky T. Tong, Daniel C. Chung, Dushyant V. Sahani, Sanjeeva P. Kalva, Sergey V. Kozin,

Nature Medicine

AngiogenesisMedicineHuman Rectal CancerImmunologyPathologyVascular BiologyDirect EvidenceCancer TreatmentNeovascularizationOncologyCancer ResearchVegf-specific Antibody Bevacizumab

References

	Year	Citations

Page 1

Page 1